Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p

References

• Varambally S, Dhanasekaran SM, Zhou M. The polycomb group protein EZH2 is involved in progression of prostate cancer[J]. Nature. 2002;419(6907):624–629.
   PubMed Web of Science ®Google Scholar
• Xing Q, Xie H, Zhu B. MiR-455-5p suppresses the progression of prostate cancer by targeting CCR5 [J]. Biomed Res Int. 2019;2019:6394784.
   PubMed Web of Science ®Google Scholar
• Huang C, Deng H, Wang Y. Circular RNA circABCC4 as the ceRNA of miR82 facilitates prostate cancer progression by promoting FOXP4 expression [J]. J Cell Mol Med. 2019;23(9). DOI:10.1111/jcmm.14477
   Web of Science ®Google Scholar
• Cheng Q, Zhang M, Zhang M, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
   PubMed Web of Science ®Google Scholar
• Hao L, Beiqin Y, Jianfang L. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer [J]. Oncotarget. 2014;5(8):2318–2329.
   PubMedGoogle Scholar
• Chakravarty D, Sboner A, Nair SS. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer [J]. Nat Commun. 2014;5(1):5383.
   PubMedGoogle Scholar
• Han P, Jing-wen L, Zhang B-M. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling [J]. Mol Cancer. 2017;16(1):1.
   PubMedGoogle Scholar
• Li L, Chen H, Gao Y. Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy [J]. Mol Cancer Ther. 2016;15(7):1535–7163. MCT-16-0008
   PubMedGoogle Scholar
• Wang X, Wang G, Zhang L, et al. LncRNA PVT1 promotes the growth of HPV positive and negative cervical squamous cell carcinoma by inhibiting TGF-β1[J]. Cancer Cell Int. 2018;18(1):70.
   PubMedGoogle Scholar
• Ma W, Zhang CQ, Li HL, et al. LncRNA FER1L4 suppressed cancer cell growth and invasion in esophageal squamous cell carcinoma [J]. European Review for Medical and Pharmacological Sciences. 2018;22(9):2638–2645.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang C, Chen R, et al. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 2016;383(1):28–40.
   PubMed Web of Science ®Google Scholar
• Khan-Malek R, Wang Y. Statistical analysis of quantitative RT-PCR results. Methods Mol Biol. 2017;1641:281–296.
   PubMedGoogle Scholar
• Pillai-Kastoori L, Schutz-Geschwender AR, Harford JA. A systematic approach to quantitative Western blot analysis. Anal Biochem. 2020;593:113608.
   PubMed Web of Science ®Google Scholar
• Mu L, Yang F, Guo D, et al. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p. Bioengineered. 2020;11(1):472–483.
   PubMed Web of Science ®Google Scholar
• Zhang SF, Zhang K, Cheng HM, et al. Comparative transcriptomics reveals colony formation mechanism of a harmful algal bloom species Phaeocystis globosa. Sci Total Environ. 2020;719:137454.
   PubMed Web of Science ®Google Scholar
• Fang J, Zhao X, Li S, et al. Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90rsk-CREB pathway. Stem Cell Res Ther. 2019;10(1):312.
   PubMed Web of Science ®Google Scholar
• Zhao L, Sun H, Kong H, et al. The Lncrna-TUG1/EZH2 axis promotes pancreatic cancer cell proliferation, migration and EMT phenotype formation through sponging Mir-382. Cell Physiol Biochem. 2017;42(6):2145–2158.
   PubMedGoogle Scholar
• Unal H. Luciferase reporter assay for unlocking ligand-mediated signaling of GPCRs. Methods Cell Biol. 2019;149:19–30.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang ZY, Zhang Z, et al. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature. Bioengineered. 2021;12(1):1725–1738.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ren X, Zhang W, et al. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers. Bioengineered. 2020;11(1):1112–1123.
   PubMed Web of Science ®Google Scholar
• Fang C, Xu L, He W, et al. Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis. Cell Cycle. 2019;18(23):3288–3299.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu G. NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway. Neurourol Urodyn. 2020;39(2):547–557.
   PubMed Web of Science ®Google Scholar
• Shan G, Tang T, Xia Y, et al. Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1. Biomed Pharmacothe. 2020;121:109248.
   PubMed Web of Science ®Google Scholar
• Zhu SP, Wang JY, Wang XG, et al. Long intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer. Aging (Albany NY). 2017;9(2):475–486.
   PubMedGoogle Scholar
• Gu Z, Hou Z, Zheng L, et al. Long noncoding RNA LINC00858 promotes osteosarcoma through regulating miR-139-CDK14 axis. Biochem Biophys Res Commun. 2018;503(2):1134–1140.
   PubMed Web of Science ®Google Scholar
• Yamada A, Yu P, Lin W, et al. A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer. Sci Rep. 2018;8(1):575.
   PubMedGoogle Scholar
• Bai X, Wang W, Zhao P, et al. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Carcinogenesis. 2020;41(1):111–121.
   PubMed Web of Science ®Google Scholar
• Chen JH, Tong W, Pu XF, et al. Long noncoding RNA CRNDE promotes proliferation, migration and invasion in prostate cancer through miR-101/Rap1A. Neoplasma. 2020;67(3):584–594.
   PubMed Web of Science ®Google Scholar
• Tang X, Wang T, Qiu C, et al. RNA (lncRNA) CRNDE Regulated Lipopolysaccharides (LPS)-Induced MRC-5 Inflammation Injury Through Targeting MiR-141. Med Sci Monit. 2020;26:e920928.
   PubMed Web of Science ®Google Scholar
• Wu Y, Hu L, Qin Z, et al. MicroRNA302a upregulation mediates chemoresistance in prostate cancer cells. Mol Med Rep. 2019;19(5):4433–4440.
   PubMed Web of Science ®Google Scholar
• Bi CW, Zhang GY, Bai Y, et al. Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer. Medicine (Baltimore). 2019;98(36):e16705.
   PubMed Web of Science ®Google Scholar
• Yang B, Zhang W, Sun D, et al. Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5. Biomed Pharmacother. 2019;109:2128–2135.
   PubMed Web of Science ®Google Scholar
• Ji L, Jiang X, Mao F, et al. miR5895p is downregulated in prostate cancer and regulates tumor cell viability and metastasis by targeting CCL5. Mol Med Rep. 2019;20(2):1373–1382.
   PubMed Web of Science ®Google Scholar
• Yan TH, Qiu C, Sun J, et al. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2018;22(10):3038–3046.
   PubMed Web of Science ®Google Scholar
• Xie H, Shi S, Chen Q, et al. LncRNA TRG-AS1 promotes glioblastoma cell proliferation by competitively binding with miR-877-5p to regulate SUZ12 expression. Pathol Res Pract. 2019;215(8):152476.
   PubMed Web of Science ®Google Scholar